Haemoglobin (Hb) variability is associated with poor survival in patients with chronic kidney disease. Association of Hb variability after kidney transplantation with patients' and graft survival has not been adequetly studied.

Methods

This retrospective study used registry data to examine the association between Hb variability in the early post-transplant period (first 6 months) and graft survival after kidney transplantatin. Kaplan–Meier and Cox regression analyses were used for univariate and multivariate associations between mortality, death censored graft survival and the composite outcome of both, in 752 patients after kidney transplantation. Hb values were collected each month during the first 6 months after transplantation, and Hb variavility was calculated using the residual standard deviation method.

Results

The highest quartile of Hb variability was associated with inferior graft and patients' survival in univariate (hazard ratio (HR) 2.18; 95% confidence interval (CI) 1.51 to 3.13; P < 0.001) and multivariate models (HR 1.5; 95% CI 1.029 to 2.18; P = 0.035). This association was mainly due to increased death censored graft failure in the high variability group (HR 2.75; 95% CI 1.73 to 4.38; P < 0.001) and (HR 1.67; 95% CI 1.023 to 2.74; P = 0.04) in the univariate and multivariate models, respectively. There was no association between Hb variability and the risk of death (HR 1.51; 95% CI 0.88 to 2.57; P = 0.132).

Conclusion

High Hb variability is independently associated with inferior graft survival in patients after kidney transplantation.

Supporting Information

References

1 Hsu CY, McCulloch CE, Curhan GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: Results from the Third National Health and Nutrition Examination Survey. J. Am. Soc. Nephrol. 2002; 13: 504–510.
10.1681/ASN.V132504
PubMed Web of Science® Google Scholar
2 Regidor DL, Kopple JD, Kovesdy CP et al. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J. Am. Soc. Nephrol. 2006; 17: 1181–1191.
10.1681/ASN.2005090997
CAS PubMed Web of Science® Google Scholar
3 Mix TC, Kazmi W, Khan S et al. Anemia: A continuing problem following kidney transplantation. Am. J. Transplant. 2003; 3: 1426–1433.
10.1046/j.1600-6135.2003.00224.x
PubMed Web of Science® Google Scholar
4 Molnar MZ, Czira M, Ambrus C et al. Anemia is associated with mortality in kidney-transplanted patients – a prospective cohort study. Am. J. Transplant. 2007; 7: 818–824.
10.1111/j.1600-6143.2006.01727.x
CAS PubMed Web of Science® Google Scholar
5 Moore J, He X, Cockwell P, Little MA, Johnston A, Borrows R. The impact of hemoglobin levels on patient and graft survival in renal transplant recipients. Transplantation 2008; 86: 564–570.
10.1097/TP.0b013e318181e276
CAS PubMed Web of Science® Google Scholar
6 Kamar N, Rostaing L. Negative impact of one-year anemia on long-term patient and graft survival in kidney transplant patients receiving calcineurin inhibitors and mycophenolate mofetil. Transplantation 2008; 85: 1120–1124.
10.1097/TP.0b013e31816a8a1f
CAS PubMed Web of Science® Google Scholar
7 Yang W, Israni RK, Brunelli SM, Joffe MM, Fishbane S, Feldman HI. Hemoglobin variability and mortality in ESRD. J. Am. Soc. Nephrol. 2007; 18: 3164–3170.
10.1681/ASN.2007010058
CAS PubMed Web of Science® Google Scholar
8 Berns JS, Elzein H, Lynn RI, Fishbane S, Meisels IS, Deoreo PB. Hemoglobin variability in epoetin-treated hemodialysis patients. Kidney Int. 2003; 64: 1514–1521.
10.1046/j.1523-1755.2003.00229.x
PubMed Web of Science® Google Scholar
9 Gilbertson DT, Ebben JP, Foley RN, Weinhandl ED, Bradbury BD, Collins AJ. Hemoglobin level variability: Associations with mortality. Clin. J. Am. Soc. Nephrol. 2008; 3: 133–138.
10.2215/CJN.01610407
CAS PubMed Web of Science® Google Scholar
10 Kalantar-Zadeh K, Aronoff GR. Hemoglobin variability in anemia of chronic kidney disease. J. Am. Soc. Nephrol. 2009; 20: 479–487.
10.1681/ASN.2007070728
CAS PubMed Web of Science® Google Scholar
11 Weinhandl ED, Peng Y, Gilbertson DT, Bradbury BD, Collins AJ. Hemoglobin variability and mortality: Confounding by disease severity. Am. J. Kidney Dis. 2011; 57: 255–265.
10.1053/j.ajkd.2010.06.013
CAS PubMed Web of Science® Google Scholar
12 Szeto CC, Kwan BC, Chow KM, Pang WF, Leung CB, Li PK. Haemoglobin variability in Chinese pre-dialysis CKD patients not receiving erythropoietin. Nephrol. Dial. Transplant. 2011; 26: 2919–2924.
10.1093/ndt/gfq824
CAS PubMed Web of Science® Google Scholar
13 Fernandez Fresnedo G, de Francisco AL, Gomez Alamillo C, Ruiz JC, Rodrigo E, Arias M. The phenomenon of hemoglobin variability with erythropoiesis stimulating agents in renal transplant patients. Clin. Nephrol. 2009; 72: 292–297.
10.5414/CNP72292
CAS PubMed Web of Science® Google Scholar
14 Kainz A, Wilflingseder J, Fugger R, Kramar R, Oberbauer R. Hemoglobin variability after renal transplantation is associated with mortality. Transpl. Int. 2012; 25: 323–327.
10.1111/j.1432-2277.2012.01428.x
CAS PubMed Web of Science® Google Scholar
15 Brunelli SM, Lynch KE, Ankers ED et al. Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients. Clin. J. Am. Soc. Nephrol. 2008; 3: 1733–1740.
10.2215/CJN.02390508
CAS PubMed Web of Science® Google Scholar
16 Boudville NC, Djurdjev O, Macdougall IC et al. Hemoglobin variability in nondialysis chronic kidney disease: Examining the association with mortality. Clin. J. Am. Soc. Nephrol. 2009; 4: 1176–1182.
10.2215/CJN.04920908
CAS PubMed Web of Science® Google Scholar
17 Winkelmayer WC, Lorenz M, Kramar R, Fodinger M, Horl WH, Sunder-Plassmann G. C-reactive protein and body mass index independently predict mortality in kidney transplant recipients. Am. J. Transplant. 2004; 4: 1148–1154.
10.1111/j.1600-6143.2004.00477.x
PubMed Web of Science® Google Scholar
18 Winkelmayer WC, Schaeffner ES, Chandraker A et al. A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients. Transpl. Int. 2007; 20: 505–511.
10.1111/j.1432-2277.2007.00472.x
CAS PubMed Web of Science® Google Scholar
19 Varagunam M, Finney H, Trevitt R et al. Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. Am. J. Kidney Dis. 2004; 43: 502–507.
10.1053/j.ajkd.2003.11.011
CAS PubMed Web of Science® Google Scholar
20 Winkelmayer WC, Lorenz M, Kramar R, Horl WH, Sunder-Plassmann G. Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients. Am. J. Transplant. 2004; 4: 2075–2081.
10.1046/j.1600-6143.2004.00604.x
PubMed Web of Science® Google Scholar
21 Brunelli SM, Joffe MM, Israni RK et al. History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients. Clin. J. Am. Soc. Nephrol. 2008; 3: 777–782.
10.2215/CJN.04281007
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume18, Issue2

February 2013

Pages 148-156

Haemoglobin variability in the early post-transplant period: Association with graft survival and mortality

Abstract

Aim

Methods

Results

Conclusion

Supporting Information

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Haemoglobin variability in the early post-transplant period: Association with graft survival and mortality

Abstract

Aim

Methods

Results

Conclusion

Supporting Information

References

Citing Literature

References

Related

Information